Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg Veins of Patients After Knee Surgery
Public ClinicalTrials.gov record NCT00306254. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2B, Randomized, Multicenter, Dose-Ranging Study Assessing the Safety and Efficacy of PD 0348292 in the Prevention of Venous Thromboembolic Events (VTE) in Subjects Undergoing an Elective, Unilateral Total Knee Replacement
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To study the safety and effectiveness of several doses of PD 0348292 compared to enoxaparin in preventing blood clots in the lungs or deep leg veins of patients after knee surgery
Study identification
- NCT ID
- NCT00306254
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 1,225 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2006 (Type not available)
- Primary completion
- Not listed
- Completion
- Jul 2007 (Actual)
- Last update posted
- Oct 10, 2007
2006 – 2007
United States locations
- U.S. sites
- 58
- U.S. states
- 10
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Birmingham | Alabama | 35205 | — |
| Pfizer Investigational Site | Birmingham | Alabama | 35209 | — |
| Pfizer Investigational Site | Little Rock | Arkansas | 72205 | — |
| Pfizer Investigational Site | North Little Rock | Arkansas | 72118 | — |
| Pfizer Investigational Site | Encinitas | California | 92024 | — |
| Pfizer Investigational Site | Fountain Valley | California | 92708-4004 | — |
| Pfizer Investigational Site | Fountain Valley | California | 92708 | — |
| Pfizer Investigational Site | Glendale | California | 91206 | — |
| Pfizer Investigational Site | La Mesa | California | 91942 | — |
| Pfizer Investigational Site | Long Beach | California | 90806 | — |
| Pfizer Investigational Site | Long Beach | California | 90813 | — |
| Pfizer Investigational Site | Long Beach | California | 92708 | — |
| Pfizer Investigational Site | Los Angeles | California | 90036 | — |
| Pfizer Investigational Site | Los Angeles | California | 90045 | — |
| Pfizer Investigational Site | Los Angeles | California | 90048 | — |
| Pfizer Investigational Site | Santa Ana | California | 92704 | — |
| Pfizer Investigational Site | Torrance | California | 90509 | — |
| Pfizer Investigational Site | Aurora | Colorado | 80011 | — |
| Pfizer Investigational Site | Aurora | Colorado | 80012 | — |
| Pfizer Investigational Site | Aurora | Colorado | 80013 | — |
| Pfizer Investigational Site | Denver | Colorado | 80230 | — |
| Pfizer Investigational Site | Englewood | Colorado | 80110 | — |
| Pfizer Investigational Site | Littleton | Colorado | 80122 | — |
| Pfizer Investigational Site | Littleton | Colorado | 80123 | — |
| Pfizer Investigational Site | Lone Tree | Colorado | 80123 | — |
| Pfizer Investigational Site | Lone Tree | Colorado | 80124 | — |
| Pfizer Investigational Site | Parker | Colorado | 80138 | — |
| Pfizer Investigational Site | Coral Gables | Florida | 33134 | — |
| Pfizer Investigational Site | Hollywood | Florida | 33021 | — |
| Pfizer Investigational Site | Miami | Florida | 33125 | — |
| Pfizer Investigational Site | Miami | Florida | 33136 | — |
| Pfizer Investigational Site | Miami | Florida | 33175 | — |
| Pfizer Investigational Site | Miami | Florida | 33186 | — |
| Pfizer Investigational Site | Orlando | Florida | 32804 | — |
| Pfizer Investigational Site | St. Petersburg | Florida | 33701 | — |
| Pfizer Investigational Site | St. Petersburg | Florida | 33703 | — |
| Pfizer Investigational Site | St. Petersburg | Florida | 33705 | — |
| Pfizer Investigational Site | St. Petersburg | Florida | 33707 | — |
| Pfizer Investigational Site | Winter Park | Florida | 32789 | — |
| Pfizer Investigational Site | Winter Park | Florida | 32792 | — |
| Pfizer Investigational Site | Flint | Michigan | 48503 | — |
| Pfizer Investigational Site | Flint | Michigan | 48507 | — |
| Pfizer Investigational Site | Rochester | New York | 14620 | — |
| Pfizer Investigational Site | Hershey | Pennsylvania | 17033 | — |
| Pfizer Investigational Site | Charleston | South Carolina | 29401 | — |
| Pfizer Investigational Site | Charleston | South Carolina | 29414 | — |
| Pfizer Investigational Site | Dallas | Texas | 75231 | — |
| Pfizer Investigational Site | Fort Worth | Texas | 76104 | — |
| Pfizer Investigational Site | Fort Worth | Texas | 76107 | — |
| Pfizer Investigational Site | Houston | Texas | 77024 | — |
| Pfizer Investigational Site | Houston | Texas | 77025 | — |
| Pfizer Investigational Site | Houston | Texas | 77030 | — |
| Pfizer Investigational Site | Lubbock | Texas | 79410 | — |
| Pfizer Investigational Site | San Antonio | Texas | 78217 | — |
| Pfizer Investigational Site | San Antonio | Texas | 78229 | — |
| Pfizer Investigational Site | San Antonio | Texas | 78233 | — |
| Pfizer Investigational Site | San Antonio | Texas | 78240 | — |
| Pfizer Investigational Site | San Antonio | Texas | 78258 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 76 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00306254, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 10, 2007 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00306254 live on ClinicalTrials.gov.